. 2024 Aug 30;16(8):e68249. doi: 10.7759/cureus.68249

Table 1. Baseline demographic and clinical characteristics of patients and among cirrhotic, and non-cirrhotic groups.

Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; TB, total bilirubin; HCV, hepatitis C virus; SD, standard deviation; RNA, Ribonucleic acid.

Note: ^a Data was presented as Mean± SD, while ^b Data was presented as n (%).

P-values of < 0.05 were considered significant.

Variables	Subgroups	Total (N=53)	Cirrhosis (N= 13, 24.5%)	Noncirrhotic (N= 40; 75.5%)	p-value
Age (year)^a	Mean ± SD	50.0 ± 15.3	61.7 ± 6.9	46.2 ± 15.4	0.001
Gender^b	Male	17 (32.1)	6 (46.2)	11 (27.5)	0.363
Gender^b	Female	36 (67.9)	7 (53.8)	29 (72.5)	0.363
Hypertension^b	No	44 (83.0)	9 (69.2)	35 (87.5)	0.272
Hypertension^b	Yes	9 (17.0)	4 (30.8)	5 (12.5)	0.272
Diabetes^b	No	41 (77.4)	8 (61.5)	33 (82.5)	0.235
Diabetes^b	Yes	12 (22.6)	5 (38.5)	7 (17.5)	0.235
Fatty liver^b	No	45 (84.9)	13 (100.0)	32 (80.0)	0.192
Fatty liver^b	Yes	8 (15.1)	0 (0.0)	8 (20.0)	0.192
Pretreatment ALT (U/L)^a	Mean ± SD	39.6 ± 18.9	51.6 ± 21.2	35.6 ± 16.6	0.007
Pretreatment AST (U/L)^a	Mean ± SD	37.1 ± 21.9	48.9 ± 27.1	33.2 ± 18.7	0.023
Pretreatment TB (mg/dL)^a	Mean ± SD	0.8 ± 0.2	0.9 ± 0.2	0.8 ± 0.2	0.140
Pretreatment ALP (IU/L)^a	Mean ± SD	3.6 ± 0.4	3.3 ± 0.4	3.6 ± 0.4	0.012
Pretreatment Viral load (HCV RNA, log10 IU/mL)^a	Mean ± SD	9912154.4 ± 37597461.8	14171118.5 ± 36691688.8	8527991.1 ± 38242745.0	0.643
Pretreatment Viral load (HCV RNA, log10 IU/mL)^b	<800000	32 (60.4)	10 (76.9)	22 (55.0)	0.281
Pretreatment Viral load (HCV RNA, log10 IU/mL)^b	>800000	21 (39.6)	3 (23.1)	18 (45.0)	0.281